179256-31-6

Basic information

• Product Name: Benzoic acid, 5-cyano-2-(phenylmethoxy)-, phenylmethyl ester
• CAS NO: 179256-31-6
• Molecular Formula: C22H17NO3
• Molecular Weight: 343.382
• Mol File: 179256-31-6.mol
• Article Data: 9

Chemical Properties

• CAS DataBase Reference: Benzoic acid, 5-cyano-2-(phenylmethoxy)-, phenylmethyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: Benzoic acid, 5-cyano-2-(phenylmethoxy)-, phenylmethyl ester(179256-31-6)
• EPA Substance Registry System: Benzoic acid, 5-cyano-2-(phenylmethoxy)-, phenylmethyl ester(179256-31-6)

Safety Data

• Hazardous Substances Data: 179256-31-6(Hazardous Substances Data)

Upstream product

• 74901-29-4 5-cyanosalicylaldehyde 
• 767-00-0 4-cyanophenol 
• 10435-57-1 5-cyano-2-hydroxybenzoic acid 
• 100-39-0 benzyl bromide 
• 616-76-2 2-hydroxy-5-formylbenzoic acid 
• 150258-60-9 benzyl 5-formyl-2-(benzyloxy)benzoate 

Downstream Products

• 518978-03-5 5-cyano-2-[(phenylmethyl)oxy]benzoic acid 
• 1204345-94-7 benzyl 2-benzyloxy-5-(1H-tetrazol-5-yl)benzoate 
• 10435-57-1 5-cyano-2-hydroxybenzoic acid 

Relevant articles and documents

METHODS OF TREATING CREATINE TRANSPORTER DEFICIENCY

Disclosed are methods of treating creatine transporter deficiency, comprising administering to a mammal in need thereof a therapeutically effective amount of a compound that increases transport of a substrate by a mutant or wild-type creatine transporter. Also disclosed are methods of increasing transport of guanidinoacetic acid or a salt thereof across the blood-brain barrier of a mammal, and methods of decreasing accumulation or the concentration of guanidinoacetic acid or a salt thereof in a mammalian cell.

INHIBITORS AGAINST THE ACTIVATION OF AP-1 AND NFAT

A medicament inhibiting the activation of AP-1 which comprises as an active ingredient a substance selected from the group consisting of a compound represented by the following general formula (I) and a pharmacologically acceptable salt thereof, and a hydrate thereof and a solvate thereof: wherein X represents a connecting group whose number of atoms in the main chain is 2 to 5 (said connecting group may be substituted), A represents hydrogen atom or acetyl group, E represents an aryl group which may be substituted or a hetero aryl group which may be substituted, ring Z represents an arene which may have one or more substituents in addition to the group represented by formula -O-A wherein A has the same meaning as that defined above and the group represented by formula -X-E wherein each of X and E has the same meaning as that defined above, or a heteroarene which may have one or more substituents in addition to the group represented by formula -O-A wherein A has the same meaning as that defined above and the group represented by formula -X-E wherein each of X and E has the same meaning as that defined above.

IMMUNITY-RELATED PROTEIN KINASE INHIBITORS

[From equivalent EP1510210A1] A medicament having an inhibitory activity against IKK-Aβ and/or MEKK-1 or other protein kinases structurally similar thereto, which comprises as an active ingredient a substance selected from the group consisting of a compound represented by the following general formula (I) and a pharmacologically acceptable salt thereof, and a hydrate thereof and a solvate thereof: wherein X represents a connecting group whose number of atoms in the main chain is 2 to 5 (said connecting group may be substituted), A represents hydrogen atom or acetyl group, E represents an aryl group which may be substituted or a hetero aryl group which may be substituted, ring Z represents an arene which may have one or more substituents in addition to the group represented by formula -O-A wherein A has the same meaning as that defined above and the group represented by formula -X-E wherein each of X and E has the same meaning as that defined above, or a heteroarene which may have one or more substituents in addition to the group represented by formula -O-A wherein A has the same meaning as that defined above and the group represented by formula -X-E wherein each of X and E has the same meaning as that defined above.